Bearish
QuidelOrtho Q1 2026 slides: revenue falls 13%, respiratory weakness pressures margins
QuidelOrtho reported a challenging Q1 2026 with revenue falling 13% to $620 million and an adjusted diluted loss per share of $0.04, significantly mis...